CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

February 8, 2024 · earnings

VNDA earnings: a positive outcome, +11.8%

On February 8, 2024, Vanda Pharmaceuticals Inc. reached its earnings. The result was a positive outcome, and the stock moved +11.8% in the window around the event. It had already run -16.8% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$3.64
1d before
$4.07
Event day
$4.16
1d after
$4.06
5d after

Pre-catalyst setup

-16.8%
30-day run-up
4846%
30-day volatility
0.9×
volume spike